Spine Specialists On-Call: Charité Artificial Disc

Peer Reviewed

With the approval of the Charité Artificial Disc (DePuy Spine, Inc.) on October 26, 2004, the dawning of a new era of spine surgery began. Disc replacement is the most significant advancement since the modern treatment of spinal disorders began 70 years ago. Further, disc replacement introduces a new era of motion preserving surgeries that will include facet joint replacement, nucleus replacement, and minimally invasive motion preservation devices. Spinal arthroplasty is similar to the development of total hip and knee replacements.

”CHARITE
Charité Artificial Disc
Photo Courtesy of DePuy Spine, Inc.

Lives Improved
The lives of millions of patients will change for the better. Having been one of the original United States (US) investigators during the Food and Drug Administration (FDA) study of the Charité Artificial Disc during the last four and one-half years, I can honestly say that this is one of the most satisfying operations that I perform. To see patients who have suffered with chronic back pain for years only to return to normal pain free lives is truly amazing.

Patient Outcomes
But the patient must be wary, because not all patients can expect to be "normal". The FDA study of the Charité Artificial Disc showed that patients had less pain and better function than the fusion patients and that they were happier. They were not however totally pain free. In my personal series, about 40% of patients were pain free while the others were improved.

Surgical Challenge
We have learned through our studies that patient selection is extremely important and proper placement of the artificial disc is important to obtain the best possible results. The challenge for the surgical community is to select patients by adhering to the same strict criteria of the study, obtain proper training in the implantation of these devices, and perform the surgery properly to maximize the results.

Realistic Expectations Necessary
The challenge for the patient is to have realistic expectations. Not every patient will be able to be pain free or "hit the home run", as I explain to my patients. The patient should choose his or her surgeon based on the surgeon's experience with such surgery. Do not be afraid to ask how many surgeries the surgeon has done.

Finally the patient should do his or her research. There will be at least three other artificial discs released in the next couple of years: ProDisc® (Synthes Spine), Maverick (Medtronic Sofamor Danek), and Flexicore (Stryker Spine). They all will be compared with the Charité Artificial Disc, which has a 17-year track record outside of the US.

To learn about Dr. Guyer’s practice, click here.

Updated on: 09/20/16
Continue Reading
Lumbar (Low Back) Artificial Discs: Spine Technology Update
Todd Albert, MD
Dr. Guyer very eloquently conveys the potential benefits of this new technological advance in the treatment of low back pain due to single level disc degeneration. He appropriately emphasizes the need for realistic expectations on the patient's part. After all, Artificial Disc Replacement is still a treatment for low back pain, historically our least understood disease entity, and our least successfully treated entity using a surgical approach.

It would be unrealistic to believe that artificial disc replacement is going to be significantly superior to our classic treatment (lumbar fusion) given the results of the U.S. IDE study for the Charite device. Patients, however, may be more mobile earlier with disc replacement.

Cautious adoption and careful long-term study will better identify the strengths and weaknesses of this exciting technology.

SHOW MAIN MENU
SHOW SUB MENU
Cancel
Delete
Continue Reading:

Lumbar (Low Back) Artificial Discs: Spine Technology Update

Dr. Jack Zigler, an orthopaedic spine surgeon, talks with SpineUniverse about the history of lumbar (low back) artificial discs and how they differ.
Read More